WHO Grants First-Ever Approval for Malaria Treatment in…

WHO Grants First-Ever Approval for Malaria Treatment in Newborns and Infants Category: Infectious Disease | Pediatrics | Global Health Date: April 2026 Malaria remains one of the world's deadliest infectious diseases, claiming more than 600,000 lives annually, the majority of them children under five in sub-Saharan Africa. For decades, malaria treatment options for the youngest and most vulnerable patients have been severely limited, with most approved therapies designed for older children and adults. In a historic milestone announced in April 2026, the World Health Organization granted prequalification approval to a malaria treatment specifically formulated for newborns and infants, the first of its kind ever. What the Research Found The WHO prequalification marks the culmination of years of pediatric-specific clinical research demonstrating that the approved treatment is both safe and effective in the